☆ 4.7 Article

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study

LEUKEMIA (2021)

Get Full Text
Add to Collection

Journal

LEUKEMIA
Volume 35, Issue 1, Pages 235-238

Publisher

SPRINGERNATURE
DOI: 10.1038/s41375-020-0833-x

Keywords

-

Categories

Oncology Hematology

Funding

  1. Associazione Italiana Ricerca Cancro (AIRC), Milan Italy Investigator Grant [IG-21687]
  2. Ministero della Salute, Rome, Italy [PE 2016-02362756]
  3. AIRC Grant 5x1000 [9980]
  4. AIRC [16695, IG-21352]
  5. Fondazione CaRiCal [16695]
  6. AIRC 5x1000, Metastases Special Program, Milan, Italy [21198]
  7. MoH, Rome, Italy [RF-2011-02349712]
  8. MIUR, Rome, Italy [PRIN 2015ZMRFEA_004]
  9. AGING Project-Department of Excellence-DIMET, UPO, Novara, Italy
  10. GILEAD Sciences Srl

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.